International Journal of Research and Review E-ISSN: ; P-ISSN:

Similar documents
International Journal of Health Sciences and Research ISSN:

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC

Skeletal Manifestations

Managing menopause in Primary Care and recent advances in HRT

Osteoporosis. Overview

Using the FRAX Tool. Osteoporosis Definition

1

Managing menopause in Primary Care and recent advances in HRT

Guideline for the investigation and management of osteoporosis. for hospitals and General Practice

This includes bone loss, endometrial cancer, and vasomotor symptoms.

Aromatase Inhibitors & Osteoporosis

Volume 7, Issue 1, January 2018, e-issn:

Overview. Bone Biology Osteoporosis Osteomalacia Paget s Disease Cases. People Centred Positive Compassion Excellence

Assessment of Nutritional Adequacy of Perimenopausal and Menopausal Working Women of Allahabad

Screening for absolute fracture risk using FRAX tool in men and women within years in urban population of Puducherry, India

NGUYEN THI NGOC LAN- TAO THI MINH THUY

JMSCR Vol 04 Issue 12 Page December 2016

DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN

An audit of osteoporotic patients in an Australian general practice

Menopause & HRT. Rosie & Alex. Image:

Use of DXA / Bone Density in the Care of Your Patients. Brenda Lee Holbert, M.D. Associate Professor Senior Staff Radiologist

COPD-Related Musculoskeletal Disease. Jessica Bon Field, MD, MS 2017 Update in Internal Medicine October 20, 2017

Helpful information about bone health & osteoporosis Patient Resource

Beyond the T-score: New Thinking in Osteoporosis 2

Pharmacy Management Drug Policy

Comparison of Dietary Supplement Intake between Healthy Individuals and Osteoporosis Patients in Gorgan, Iran

CASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology

HIV and your Bones Osteopenia and Osteoporosis

06-Mar-17. Premature menopause. Menopause. Premature menopause. Menstrual cycle oestradiol. Premature menopause. Prevalence ~1% Higher incidence:

The Better Health News2

Osteoporosis challenges

Osteoporosis Clinical Guideline. Rheumatology January 2017

Closing the Care Gap in Osteoporosis ICE Conference 2015

Bone Density Measurement in Women

Pharmacy Management Drug Policy

OSTEOPOROSIS IN INDONESIA

Long term Sequelae in Natural and Surgical Menopause

Chapter 39: Exercise prescription in those with osteoporosis

Tel: (312) Women s Integrated Fax: (312) Pelvic Health Program. 1.0: Basic Information. Preferred Language:

Measuring Bone Mineral Density

North American Menopause Society (NAMS)

BONE HEALTH Dr. Tia Lillie. Exercise, Physical Activity and Osteoporosis

Make your. first break. your last.

Building Bone Density-Research Issues

Management of osteoporosis in women - A prevalence and interventional study

Bone Densitometry Pathway

1405 NE Douglas Lee s Summit, MO Phone: Date: Fax: Female Information and Health Summary

[If no, skip to question 10.] Y N. 2. Does the member have a diagnosis of Paget s disease of bone? Y N. [If no, skip to question 4.

3. Has bone specific alkaline phosphatase level increased OR does the member have symptoms related to active Paget s?

Evaluation Of The Efficacy And Tolerability Of Micronutrient Supplementation In Treatment Of Post Menopausal Symptoms

Objectives: What is Osteoporosis 10/8/2015. Bone Health/ Osteoporosis: BASICS OF SCREENING, INTERPRETING, AND TREATING

Case Finding and Risk Assessment for Osteoporosis

International Journal of Health Sciences and Research ISSN:

Please answer all questions in blue or black ink by filling in the blank or circling. SOCIAL HISTORY

Bone Mass Measurement BONE MASS MEASUREMENT HS-042. Policy Number: HS-042. Original Effective Date: 8/25/2008

Name: Date of Birth: Age: Address: City State Zip

Dumfries and Galloway. Treatment Protocol for Osteoporosis

Bone Mineral Density and Its Associated Factors in Naresuan University Staff

DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi

HORMONES AND YOUR HEALTH Charlie Tucker Pharm. D

Osteoporosis - New Guidelines. Michelle Glass B.Sc. (Pharm) June 15, 2011

Effective risk assessment tools for osteoporosis in the Indian menopausal female

Osteoporosis: Who, What, When, Why, and How

Pharmacy Management Drug Policy

Evaluation Of The Efficacy And Tolerability Of Micronutrient Supplementation In Treatment Of Post Menopausal Symptoms

LOVE YOUR BONES Protect your future

EVALUATION OF WOMEN FOLLOWING HYSTERECTOMY WITH AND WITHOUT CONSERVATION OF OVARIES

Original article Pravara Med Rev 2010; 2(3)

Dumfries and Galloway. Treatment Protocol for Osteoporosis

Australian Journal of Basic and Applied Sciences

Northeast Ohio Urogynecology Patient History Intake Form. Last Name First Name Age. Date of Birth Race Referring Physician.

Post-menopausal hormone replacement therapy. Evan Klass, MD May 17, 2018

HORMONE BALANCE QUESTIONNAIRE FOR WOMEN

Risk factors associated with low bone mineral density in Ajman, UAE

John J. Wolf, DO Family Medicine

Gynecological Symptoms in Apparently Asymptomatic Women

FRAX, NICE and NOGG. Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield

Osteoporosis in Men Wendy Rosenthal PharmD. This program has been brought to you by PharmCon

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Osteoporosis. Current Trend in Osteoporosis Management for Elderly in HK- Medical Perspective. Old Definition of Osteoporosis

New 2010 Osteoporosis Guidelines: What you and your health provider need to know QUESTIONS&ANSWERS

AACE/ACE Osteoporosis Treatment Decision Tool

Osteoporosis Knowledge Assessment among Medical Interns

Updates in Osteoporosis. I have no conflicts of interest. What Would You Do? Mrs. C. What s New in Osteoporosis. Page 1

Challenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA

Prevalence Of Vitamin D Inadequacy In Peri And Postmenopausal Women Presented At Dow University Hospital, Ojha Campus. A Cross Sectional Study

Ohio Northern University HealthWise. Authors: Alexis Dolin, Andrew Duska, Hannah Lamb, Eric Miller, Pharm D Candidates 2018 May 2018

Osteoporosis/Fracture Prevention

MenoChat. City State Zip Code. Employer Job Title. Primary Care Provider Phone: History. Desired Outcome:

Menopause - a summary of management

Effective Health Care Program

Osteoporosis: Are your bones at risk of fracturing? Rachel Wallwork, MD Internal medicine resident Massachusetts General Hospital

Osteoporosis: fragility fracture risk. Costing report. Implementing NICE guidance

New Developments in Osteoporosis: Screening, Prevention and Treatment

Osteoporosis and Bone Health. Heather Schickedanz, MD Geriatric Knowledge Network, 08/10/16

Page 1

Management of postmenopausal osteoporosis

Fractures: Epidemiology and Risk Factors. July 2012 CME (35 minutes) 7/24/ July12 1. Osteoporotic fractures: Comparison with other diseases

Transcription:

International Journal of Research and Review www.gkpublication.in E-ISSN: 2349-9788; P-ISSN: 2454-2237 Original Research Article Risk Assessment of Osteoporosis in Postmenopausal Women Dr Savita Tamaria 1, Dr Anuradha Tamaria 2 1 Assistant Professor, Banarsidas Chandiwala Institute of Physiotherapy, Kalkaji, New Delhi 2 Consultant, Max Super Speciality Hospital, Saket, New Delhi Corresponding Author: Savita Tamaria ABSTRACT Introduction: Postmenopausal osteoporosis is recognized to be a major health problem and is preventable to some extent. In the Indian scenario, inadequate dietary calcium intake, low physical activity and low body weight are important risk factors for postmenopausal osteoporosis. Objective: To determine the usefulness of risk assessment and screening for osteoporosis in a hospital based population of postmenopausal women. Materials & Methods: This was a prospective observational study conducted in the department of obstetrics and gynecology of a North Indian tertiary care hospitals. It included a cross-section of 200 postmenopausal females attending gynecology OPD and Menopausal clinic. Women were screened for 10 year risk of major osteoporosis related fracture using FRAX WHO FRACTURE RISK ASSESSMENT TOOL. DEXA scan was done for women having one or more risk factors for osteoporosis and WHO criteria was used to diagnose osteoporosis. Result: Of the 200 postmenopausal women screened 90 women had one or more than one risk factor for osteoporosis. Out of 90 women, 36 (40%) were found to have osteoporosis while 49 (54.4%) women were osteopenic. Low body weight, decrease physical activity and poor dietary calcium intake were the most commonly observed risk factors in 49%, 25% and 40.5% respectively. There was a strong association between age > 65yrs and osteoporosis (p=0.007). Low body weight and poor dietary calcium intake were also significantly associated with osteoporosis (p=0.027,p=0.021). Conclusion: Evaluation of postmenopausal women by screening for risk factors was found to be a powerful tool to define the risk status for osteoporosis. Low body weight and poor dietary calcium are modifiable risk factors for developing osteoporosis. Key words: Osteoporosis, Post Menopausal. INTRODUCTION Postmenopausal osteoporosis is recognized to be a major health probable and most preventable. According to world Bank report the worldwide population of postmenopausal women which was 470 million in 1990 is expected to increase to 1.2 billion by the year 2030 and 76% of these women will be living in the [1] developing countries. Postmenopausal females in the Indian population are at a higher risk of osteoporosis because data indicate that Indians have lower bone density than their North American counterparts [2-4] and osteoporosis fracture occurs 10-20 years earlier in Indian as compared to Caucasians. [2] In India. It is projected that by the year 2030, the population of postmenopausal women will be second highest in the world, second to that of China. [5] MATERIALS AND METHODS This study is a prospective observational study carried out at a North Indian tertiary care hospitals, in the International Journal of Research & Review (www.gkpublication.in) 56

department of Obstetrics and Gynecology. It included a cross-section of postmenopausal females attending gynecological OPD and Menopause Clinic. INCLUSION CRITERIA Post menopausal women, age more than 40 yrs, cessation of period more than 1yr EXCLUSION CRITERIA The women with pre-existing coronary heart disease, osteoporosis, psychological disorders, breast and genital malignancies, surgical/premature menopause (<40 yrs) and noncompliant patients unable to adhere to study protocol were excluded from the study. All the enrolled women were evaluated regarding age, parity, obstetric history, menstrual history, duration of menopause. A detailed personal, past and present medical & family history was taken with a view to assess the risk for osteoporosis. A thorough general physical, systemic and pelvic examination was carried out. The diagnosis of osteoporosis is based on the measurement of BMD levels which can be interpreted as per WHO criteria (Appendix 1) and modified by International osteoporotic foundation. [6,7] DEXA, Quantitative USG and qct, Single Energy absorptiometry are the various diagnostic modalities for BMD measurement. [6] Further risk stratification for cost effective treatment of postmenopausal osteoporosis was facilitated by WHO FRAX algorithm (Appendix 2) which uses clinical risk factors, BMD and country specific fracture and mortality data to quantify a patient s 10 year probability of hip or major osteoporotic fracture. [6] STATISTICS The data was analysed using student t- test, chi square and co-relation coefficient analysis. A logistic regression was performed to assess the impact of the factors known to be important in the prevalence of the osteoporosis. A p value <0.05 was considered significant. RESULTS FIG/ TABLE 1: DISTRIBUTION OF VARIOUS SYMPTOMS SYMPTOMS N (=200) Percentage (%) GYNAECOLOGICAL Post menopausal bleeding 19 9.5 Prolapse 22 11 Discharge Pruritis 16 8 Without Pruritis 17 8 Pain/ Burning sensation in vulva 26 13 Vaginal Dryness 44 22 URINARY Burning micturation 49 24.5 Frequency 53 26.5 Incontinence 47 23.5 CLIMACTERIC Vasomotor Hot flashes 72 36 Night Sweats 43 21.5 Palpitations 39 19.5 Psychological feeling tense/ nervous 57 28.5 loss of interest 29 14.5 crying spells 6 3 Depression 47 23.5 Irritability 63 31.5 Fatigue/ lack of energy 110 55 Sleep disturbance 69 34.5 Decrease concentration 68 34 Decrease Memory 26 13 Psychosomatic Joint pain 83 45.5 backache 69 34.5 Sexual Loss of libido 65 32.5 Dyspareunia 44 22 Miscellanious Lump Abdomen 3 1.5 Others including routine health check up. 5 2.5 A total of 200 postmenopausal patients (>40 yrs) willing to comply with the study protocol were included. The mean presenting age of the women in the study was 57.9 ± 9.4 years and the mean age at menopause was 46.8±2.9 years. The distribution of gynaecological symptoms is depicted in [Table/ Fig-1]. The commonest gynaecological presenting symptom was vaginal dryness, while the commonest vasomotor symptom was hot flashes. One women may have one or > one risk factors. In the present study, amongst 200 women, 90 (45%) were identified to have one or more risk factors for osteoporosis, hence were candidates for primary prevention (Table 2). 39 (19.5%) were more than 65 years of age. Low body weight, inadequate dietary intake of calcium and decreased physical activity were most commonly associated risk factors in 118 (59%), International Journal of Research & Review (www.gkpublication.in) 57

21(40.5%) and 50 (25%) of women respectively. 7 (3.5%) women were smokers, while 5 (2.5%) had family history of fracture. 3 (1.5%) women had history of oral steroid intake for >3 months for various medical illnesses. [Table/Fig-2]. There was a strong association between the age and osteoporosis (p=0.007). FIG /TABLE 2: DISTRIBUTION OF VARIOUS RISK FACTORS FOR OSTEOPOROSIS Risk Factors N (=200) Women without Women with P value Osteoporosis (n=164) Osteoporosis * (n=36) Age 65 years 39 (19.5%) 9 30 0.007 Major risk factors Weight <117lbs 98(49%) 76 22 0.027 Smoking 7(3.5%) 4 3 0.069 Family history of fracture in a first degree relative 5(2.5%) 3 2 0.022 History of steroid intake for > 3 months 3(1.5%) 0 3 0.038 Past history of fracture as an adult 0 0 0 - Additional risk factors Poor calcium / V-D intake 81( 40.5) 50 31 0.021 decreased physical activity 105(2.5%) 72 33 0.084 FIG/TABLE 3: PREVALENCE OF OSTEOPOROSIS/OSTEOPENIA AS PER WHO CRITERIA MEASURED BY DEXA IN 90 WOMEN WITH RISK FACTORS *. Diagnosis N (=90) Mean t-score (Hip) ± SD Osteopenia 49 (54.44%) -1.7 ± 0.4 Osteoporosis 36 (40.00%) -3.1 ± 0.9 Normal Study 5 (5.56%) 1.2 ± 0.6 Appendix I Amongst the 90 women with risk factors, 36 (40%) women were found to have osteoporosis and 49 (54.4%) women were osteopenic. 5 (5.56%) women had normal BMD. FIG/ TABLE 4: SCREENING FOR 10 YEAR RISK OF * MAJOR OSTEOPOROSIS ASSESSMENT TOOL RELATED FRACTURE IN WOMEN WITH RISK FACTORS (N=90) USING FRAX WHO FRACTURE RISK Fracture Risk N (=90) Percentage (%) Low Risk (1-10 %) 47 47.78 Moderate (10-20%) 37 41.1 High (>20%) 6 6.7 *Appendix II It was observed that 47.78% women were at low risk, 41.1% women at moderate and 6.7% women were at higher risk of major osteoporosis related fracture [Table/Fig-4] as per WHO FRAX algorithm (Appendix II). DISCUSSION Postmenopausal females in the Indian population are at a higher risk of osteoporosis because data indicate that Indians have lower bone density and osteoporosis fracture occurs 10-20 years earlier in Indian as compared to Caucasiuans. [2] Thomas et al in their study of ambulatory postmenopausal women from Southern India also observed that the mean dietary calcium intake was much lower than the recommended intake for these women. [8] Similar observations were also made by Chibber et al, who observed that the higher prevalence of osteoporosis in women of lower socio-economic status is probably related to their lower nutritional status. [9] Thus a protective role of certain nutritional dietary components can be exploited in preventive educational strategies in Indian women. Prevalence Fig. 5 prevalence of Osteoporosis/Osteopenia as per WHO criteria measured by DEXA in 90 women with risk factors. In the present study, amongst 200 women, 90 (45%) were identified to have one or more risk factors for osteoporosis, hence were candidates for primary prevention. 39 (19.5%) were more than 65 years of age. Low body weight, inadequate dietary intake of calcium and decreased International Journal of Research & Review (www.gkpublication.in) 58

physical activity were most commonly associated risk factors in 118 (59%), 21(40.5%) and 50 (25%) of women respectively. 7 (3.5%) women were smokers, while 5 (2.5%) had family history of fracture. 3 (1.5%) women had history of oral steroid intake for >3 months for various medical illnesses. Out of 90 postmenopausal women with risk factors, 36 (40.9%) women were found to have osteoporosis and 49 (54.4%) were osteopenic. The overall prevalence of osteoporosis and osteopenia was 18% and 24.5% respectively. Our observations were similar to those reported by Thomas P et al who reported the prevalence of osteoporosis to be 16.7%. [8] The prevalence of osteopenia observed in the present study was 24.5%, which is similar to that reported by Chibber et al (29%). [9] FRAX WHO Fracture Risk Assessment Fig. 6: 10 year risk of major osteoporosis related fracture in women with risk factors (n=90) using FRAX WHO FRACTURE RISK ASSESSMENT TOOL WHO FRAX algorithm was used to calculate 10 year absolute fracture probability for both hip fracture and other major osteoporotic fractures, taking into account hip BMD and 9 other clinical risk [6] factors. The Current National Osteoporosis Foundation Guide recommends treating patients with FRAX 10 year risk scores of > or = 3% for hip fracture or > or = 20% for major osteoporotic fracture, to reduce their [6] fracture risk. In the present study, according to WHO FRAX scoring system for screening for 10 year fracture risk in high risk women, it was observed that 47 (52.2%) women were at low risk, 37 (41.1%) were at moderate risk and 6 (6.7%) were at high risk. In the Indian scenario, inadequate dietary calcium intake, low physical activity and low body weight are important risk factors for postmenopausal osteoporosis. CONCLUSION In the Indian scenario, inadequate dietary calcium intake, low physical activity and low body weight are important risk factors for postmenopausal osteoporosis. Hence a balanced diet intake, appropriate exercise and cessation of smoking are modifiable risk factors which can improve the bone health in postmenopausal women in India. Comprehensive evaluation by screening for risk factors and risk assessment was found to be a powerful tool to define the risk status for diseases common to this age group and for sensitizing women towards lifestyle modifications to improve postmenopausal health. All the postmenopausal women presenting to the OPD should be evaluated by a comprehensive holistic approach in the outpatient setting, to understand her needs and to formulate appropriate goals Counselling regarding modifiable lifestyle risk factors should be done in all women to reduce their risk of various health problems. LIMITATIONS OF STUDY This is a hospital based study, so results may not be applicable to general postmenopausal population. The sample size is also small compared to the population based studies. REFERENCES 1. World bank. World development report 1993:investing in health. New York, NY, Oxford University Press, 1993. 2. Gupta A. Osteoporosis in India- the nutritional hypothesis. In: Metabolic bone disorders. Indian Society for Bone International Journal of Research & Review (www.gkpublication.in) 59

and Mineral Research, Eds: Mithal A, Rao DS, Zaidi M. 1998; 115-132. 3. Nangia S, Arya V, Gujral RB, Mithal A. Spinal bone mineral density in normal Indian females In: Metabolic Bone Disorders. Indian Society for Bone and Mineral Research, Eds: Mithal A, Rao DS, Zaidi M. 1998: 213. 4. Arya V, Nangia S, Gujral RB, Mithal A. Femoral bone mineral density in normal Indian females In: Metabolic Bone Disorders. Indian Society for Bone and Mineral Research, Eds: Mithal A, Rao DS, Zaidi M. 1998: 213. 5. Shah RS, Savardekar LS. Postmenopausal Osteoporosis in India: Growing Public Health Concern. National Institute for Research in Reproductive Health (ICMR), Presentation made at Forum 9, Mumbai, India, 2005; 12-16. 6. World Health Organisation. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: technical report series 843. Geneva: WHO, 1994. 7. Karis JA, Gluer CC. For the committee of scientific advisor, International Osteoporosis Foundation. An update on the diagnosis and assessment of Osteoporosis with Densitometry Osteoporosis Int 2000; 11 : 192-202. 8. Paul TV, Thomas N, Sheshadari Ms, Oommen R, Jose A, Mahendari NV. Prevalence of Osteoporosis in Ambulatory Postmenopausal Women from a Semiurban Region in Southern India: Relationship to Calcium Nutrition and Vitamin D Status. Endocrine Practice 2008; 14 (6): 665-71. 9. G, Roy R, Eunica M, et al. Prevalence of Osteoporosis among elderly women living in Delhi and Haryana. Indian Journal of Endocrine Medicine 2009; 11 (1&2): 11-14. APPENDIX: I W H O CLASSIFICATION OF THE OSTEOPOROSIS Normal: BMD or bone mineral content (BMC) not more than 1 SD below the young adult mean (T-score above -1). Osteopenia (or low bone mass): BMD or BMC between 1 and 2.5 SD below young adult mean (T-score between -1 and -2.5) Osteoporosis: BMD or BMC 2.5 SD or more below the young adult mean (T-score at or below -2.5) Severe Osteoporosis (or established osteoporosis): BMD or BMC 2.5 SD or more below the young adult mean in the presence of one or more fragility fractures. Reference: World Health Organisation. Assessment of fracture risk and its application to Screening for postmenopausal osteoporosis: technical report series 843. Geneva: WHO, 1994. APPENDIX: II FRAX WHO FRACTURE RISK ASSESSMENT TOOL Questionnaire to calculate the 10 year probability of fracture with BMD 1. Age (between 40-90 years) or Date of birth 2. Sex Ο Male Ο Female 3. Weight (kg) 4. height (cm) 5. Previous fracture Ο No Ο Yes 6. Parent fractured hip Ο No Ο Yes 7. Current smoking Ο No Ο Yes 8. Rheumatoid arthritis Ο No Ο Yes International Journal of Research & Review (www.gkpublication.in) 60

9. Glucocorticoids Ο No Ο Yes 10. Secondary osteoporosis Ο No Ο Yes 11. Alcohol 3 units per day Ο No Ο Yes 12. BMD (g/cm2) Calculate Risk Reference: World Health Organisation. Assessment of fracture risk and its application to Screening for postmenopausal osteoporosis: technical report series 843. Geneva: WHO, 1994. Results: Fracture Risk- Low Risk (1-10 %) Moderate (10-20%) High (>20%) How to cite this article: Tamaria S, Tamaria A. Risk assessment of osteoporosis in postmenopausal women. International Journal of Research and Review. 2017; 4(7):56-61. ****** International Journal of Research & Review (www.gkpublication.in) 61